FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

SCA Pharmaceuticals SUCcinylcholine Chloride 200 mg/10mL Recall

SUCcinylcholine Chloride 200 mg/10mL Injection (Concentration = 20mg/mL), 10 mL fill 12…

SCA Pharmaceuticals, LLC · Windsor, CT

Risk level
Class II
Reported by FDA
Apr 3, 2024
Recall ID
D-0423-2024
Check your lot numberHow we source this data

Summary

SCA Pharmaceuticals recalled SUCcinylcholine Chloride 200 mg/10mL starting Nov 9, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0423-2024 on Apr 3, 2024. Reason: Lack of Assurance of Sterility. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility

Product description

SUCcinylcholine Chloride 200 mg/10mL Injection (Concentration = 20mg/mL), 10 mL fill 12 mL Syringe, Rx only, Repackaged by SCA Pharma, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0908-12, Bar Code 70004090812

Lot numbers, UPCs & expiration codes

Lot #: 1223049047 Exp 11/29/23; 1223049221 Exp 12/06/23; 1223049343 Exp 12/12/23; 1223049423 Exp 12/14/23; 1223049451 Exp 12/14/23; 1223049452 Exp 12/14/23; 1223049482 Exp 12/14/23

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0423-2024
Classification
Class II
Status
Terminated
Recall initiated
Nov 9, 2023
FDA report date
Apr 3, 2024
Quantity
8,755 syringe
Recall type
Voluntary: Firm initiated
Recalling firm
SCA Pharmaceuticals, LLC

Original FDA data

Every field from FDA enforcement report D-0423-2024, exactly as published.

Show all FDA fields
City
Windsor
State
CT
Status
Terminated
Country
United States
Event ID
93456
Address
755 Rainbow Rd Ste B
Code information
Lot #: 1223049047 Exp 11/29/23; 1223049221 Exp 12/06/23; 1223049343 Exp 12/12/23; 1223049423 Exp 12/14/23; 1223049451 Exp 12/14/23; 1223049452 Exp 12/14/23; 1223049482 Exp 12/14/23
Postal code
06095-1024
Report date
Apr 3, 2024
Product type
Drugs
Recall number
D-0423-2024
Classification
Class II
Recalling firm
SCA Pharmaceuticals, LLC
Product quantity
8,755 syringe
Termination date
Aug 27, 2024
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
SUCcinylcholine Chloride 200 mg/10mL Injection (Concentration = 20mg/mL), 10 mL fill 12 mL Syringe, Rx only, Repackaged by SCA Pharma, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0908-12, Bar Code 70004090812
Distribution pattern
Nationwide in the USA
Recall initiation date
Nov 9, 2023
Initial firm notification
Letter
Center classification date
Mar 22, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0423-2024, published Apr 3, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls